SGOCO Group, Ltd. (SGOC) At $1.16 Forms Bottom; ZELDA THERAPEUTICS LTD ORD AUSTR (ZLDAF) Shorts Decreased By 74.6%

SGOCO Group, Ltd. (SGOC) formed multiple bottom with $1.10 target or 5.00% below today’s $1.16 share price. SGOCO Group, Ltd. (SGOC) has $17.01 million valuation. The stock increased 2.65% or $0.03 during the last trading session, reaching $1.16. About 64,532 shares traded. SGOCO Group, Ltd. (NASDAQ:SGOC) has declined 59.30% since February 12, 2017 and is downtrending. It has underperformed by 76.00% the S&P500.

ZELDA THERAPEUTICS LTD ORD AUSTR (OTCMKTS:ZLDAF) had a decrease of 74.6% in short interest. ZLDAF’s SI was 12,700 shares in February as released by FINRA. Its down 74.6% from 50,000 shares previously. With 73,500 avg volume, 0 days are for ZELDA THERAPEUTICS LTD ORD AUSTR (OTCMKTS:ZLDAF)’s short sellers to cover ZLDAF’s short positions. It closed at $0.1 lastly. It is down 0.00% since February 12, 2017 and is . It has underperformed by 16.70% the S&P500.

Zelda Therapeutics Limited, a bio-pharmaceutical company, focuses on developing a range of cannabinoid formulations for the treatment of various medical conditions in Australia. The company has market cap of $73.93 million. The firm is involved in a human clinical trial program focused on insomnia, autism, and eczema; and a pre-clinical research program to examine the effect of cannabinoids in breast, brain, and pancreatic cancer. It currently has negative earnings. It has strategic alliances with Knop Laboratories and CannPal Pty Ltd; and partnerships with AusCann Limited and Aunt Zelda’s Inc, as well as the Complutensé University, the Curtin University, and the Telethon Kids Institute.